retatrutide triple agonist clinical trial π¨ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type 2 diabetes. π Mean body weight change at 80 weeks: β¬οΈ Retatrutide vs Tirzepatide: Which Peptide
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 30 - Sep 4


























